Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 121

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Tuning NF-κB activity: A touch of COMMD proteins

Bartuzi, Paulina, Hofker, Marten H., van de Sluis, Bart · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Abstract

NF-κB is an important regulator of immunity and inflammation, and its activation pathway has been studied extensively. The mechanisms that downregulate the activity of NF-κB have also received a lot of attention, particularly since its activity needs to be terminated to prevent chronic inflammation and subsequent tissue damage. The COMMD family has been identified as a new group of proteins involved in NF-κB termination. All ten COMMD members share the structurally conserved carboxy-terminal motif, the COMM domain, and are ubiquitously expressed. They seem to play distinct and non-redundant roles in various physiological processes, including NF-κB signaling. In this review, we describe the mechanisms and proteins involved in the termination of canonical NF-κB signaling, with a specific focus on the role of the COMMD family in the down-modulation of NF-κB.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2013.09.014

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 71

  1. Pasparakis, 2009, Regulation of tissue homeostasis by NF-[kappa]B signalling: implications for inflammatory diseases, Nat. Rev. Immunol., 9, 778, 10.1038/nri2655 · DOI · Paper page
  2. Hansson, 2013, Inflammation and atherosclerosis, Annu. Rev. Pathol. Mech. Dis., 1, 297, 10.1146/annurev.pathol.1.110304.100100 · DOI · Paper page
  3. von Herrath, 2007, Type 1 diabetes as a relapsing-remitting disease?, Nat. Rev. Immunol., 7, 988, 10.1038/nri2192 · DOI · Paper page
  4. Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205 · DOI · Paper page
  5. Kumar, 2004, Nuclear factor-κB: its role in health and disease, J. Mol. Med. (Berl.), 82, 434, 10.1007/s00109-004-0555-y · DOI · Paper page
  6. Ghosh, 1998, NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses, Annu. Rev. Immunol., 16, 225, 10.1146/annurev.immunol.16.1.225 · DOI · Paper page
  7. Ziesché, 2013, The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB, Nucleic Acids Res., 41, 90, 10.1093/nar/gks916 · DOI
  8. Oeckinghaus, 2009, The NF-κB family of transcription factors and its regulation, Cold Spring Harb. Perspect. Biol., 1, a000034, 10.1101/cshperspect.a000034 · DOI · Paper page
  9. Ghosh, 2008, New regulators of NF-[kappa]B in inflammation, Nat. Rev. Immunol., 8, 837, 10.1038/nri2423 · DOI · Paper page
  10. Zhong, 2002, The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1, Mol. Cell, 9, 625, 10.1016/S1097-2765(02)00477-X · DOI · Paper page
  11. Phelps, 2000, Mechanism of κB DNA binding by Rel/NF-κB dimers, J. Biol. Chem., 275, 24392, 10.1074/jbc.M003784200 · DOI
  12. Sun, 2011, Non-canonical NF-[kappa]B signaling pathway, Cell Res., 21, 71, 10.1038/cr.2010.177 · DOI · Paper page
  13. Razani, 2011, Non-canonical NF-κB signaling activation and regulation: principles and perspectives, Immunol. Rev., 244, 44, 10.1111/j.1600-065X.2011.01059.x · DOI · Paper page
  14. McCool, 2012, DNA damage-dependent NF-κB activation: NEMO turns nuclear signaling inside out, Immunol. Rev., 246, 311, 10.1111/j.1600-065X.2012.01101.x · DOI · Paper page
  15. Israël, 2010, The IKK complex, a central regulator of NF-κB activation, Cold Spring Harb. Perspect. Biol., 2, a000158, 10.1101/cshperspect.a000158 · DOI · Paper page
  16. Liu, 2012, IKK biology, Immunol. Rev., 246, 239, 10.1111/j.1600-065X.2012.01107.x · DOI · Paper page
  17. Sen, 1986, Multiple nuclear factors interact with the immunoglobulin enhancer sequences, Cell, 46, 705, 10.1016/0092-8674(86)90346-6 · DOI · Paper page
  18. Renner, 2009, Autoregulatory feedback loops terminating the NF-kappaB response, Trends Biochem. Sci., 34, 128, 10.1016/j.tibs.2008.12.003 · DOI
  19. Ruland, 2011, Return to homeostasis: downregulation of NF-κB responses, Nat. Immunol., 12, 709, 10.1038/ni.2055 · DOI · Paper page
  20. Hoffmann, 2002, The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation, Science, 298, 1241, 10.1126/science.1071914 · DOI · Paper page
  21. Rao, 2010, IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response, Nature, 466, 1115, 10.1038/nature09283 · DOI · Paper page
  22. Shembade, 2012, Regulation of NF-[kappa]B signaling by the A20 deubiquitinase, Cell. Mol. Immunol., 9, 123, 10.1038/cmi.2011.59 · DOI · Paper page
  23. Ma, 2012, A20: linking a complex regulator of ubiquitylation to immunity and human disease, Nat. Rev. Immunol., 12, 774, 10.1038/nri3313 · DOI · Paper page
  24. Wolfrum, 2007, The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-κB target genes, Proc. Natl. Acad. Sci. U. S. A., 104, 18601, 10.1073/pnas.0709011104 · DOI
  25. Sun, 2009, CYLD: a tumor suppressor deubiquitinase regulating NF-[kappa]B activation and diverse biological processes, Cell Death Differ., 17, 25, 10.1038/cdd.2009.43 · DOI · Paper page
  26. Bignell, 2000, Identification of the familial cylindromatosis tumour-suppressor gene, Nat. Genet., 25, 160, 10.1038/76006 · DOI · Paper page
  27. Brummelkamp, 2003, Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-[kappa]B, Nature, 424, 797, 10.1038/nature01811 · DOI · Paper page
  28. Nikolaou, 2012, Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, Inflamm. Fibros. Cancer, Cancer Cell, 21, 738
  29. Zhang, 2006, Impaired regulation of NF-κB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice, J. Clin. Invest., 116, 3042, 10.1172/JCI28746 · DOI · Paper page
  30. Biggs, 1995, Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene, Nat. Genet., 11, 441, 10.1038/ng1295-441 · DOI
  31. Saggar, 2008, CYLD mutations in familial skin appendage tumours, J. Med. Genet., 45, 298, 10.1136/jmg.2007.056127 · DOI
  32. Massoumi, 2007, Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control, Bioessays, 29, 1203, 10.1002/bies.20677 · DOI
  33. Harhaj, 2012, Regulation of NF-κB by deubiquitinases, Immunol. Rev., 246, 107, 10.1111/j.1600-065X.2012.01100.x · DOI · Paper page
  34. Huang, 2000, A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes, Proc. Natl. Acad. Sci. U. S. A., 97, 1014, 10.1073/pnas.97.3.1014 · DOI · Paper page
  35. Tanaka, 2007, PDLIM2-mediated termination of transcription factor NF-[kappa]B activation by intranuclear sequestration and degradation of the p65 subunit, Nat. Immunol., 8, 584, 10.1038/ni1464 · DOI · Paper page
  36. Mankan, 2009, NF-κB regulation: the nuclear response, J. Cell. Mol. Med., 13, 631, 10.1111/j.1582-4934.2009.00632.x · DOI · Paper page
  37. Liu, 2007, Proinflammatory stimuli induce IKK alpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity, Cell, 129, 903, 10.1016/j.cell.2007.03.056 · DOI
  38. Tahk, 2007, Control of specificity and magnitude of NF-κB and STAT1-mediated gene activation through PIASy and PIAS1 cooperation, Proc. Natl. Acad. Sci. U. S. A., 104, 11643, 10.1073/pnas.0701877104 · DOI
  39. Maine, 2007, COMMD1 promotes the ubiquitination of NF-[kappa]B subunits through a Cullin-containing ubiquitin ligase, EMBO J., 26, 436, 10.1038/sj.emboj.7601489 · DOI · Paper page
  40. van de Sluis, 2002, Identification of a new copper metabolism gene by positional cloning in a purebred dog population, Hum. Mol. Genet., 11, 165, 10.1093/hmg/11.2.165 · DOI · Paper page
  41. Burstein, 2005, COMMD proteins, a novel family of structural and functional homologs of MURR1, J. Biol. Chem., 280, 22222, 10.1074/jbc.M501928200 · DOI · Paper page
  42. de Bie, 2006, Characterization of COMMD protein–protein interactions in NF-κB signalling, Biochem. J., 398, 63, 10.1042/BJ20051664 · DOI · Paper page
  43. Klomp, 2003, The ubiquitously expressed MURR1 protein is absent in canine copper toxicosis, J. Hepatol., 39, 703, 10.1016/S0168-8278(03)00380-5 · DOI
  44. Ganesh, 2003, The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes, Nature, 426, 853, 10.1038/nature02171 · DOI · Paper page
  45. Geng, 2009, Phosphorylation of NF-[kappa]B p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination, EMBO Rep., 10, 381, 10.1038/embor.2009.10 · DOI
  46. Mattioli, 2006, Inducible phosphorylation of NF-κB p65 at serine 468 by t cell costimulation is mediated by IKK epsilon, J. Biol. Chem., 281, 6175, 10.1074/jbc.M508045200 · DOI
  47. Buss, 2004, Phosphorylation of serine 468 by GSK-3β negatively regulates basal p65 NF-κB activity, J. Biol. Chem., 279, 49571, 10.1074/jbc.C400442200 · DOI · Paper page
  48. Mao, 2009, GCN5 is a required cofactor for a ubiquitin ligase that targets NF-κB/RelA, Genes Dev., 23, 849, 10.1101/gad.1748409 · DOI
  49. Burstein, 2004, A novel role for XIAP in copper homeostasis through regulation of MURR1, EMBO J., 23, 244, 10.1038/sj.emboj.7600031 · DOI · Paper page
  50. Zoubeidi, 2010, Clusterin facilitates COMMD1 and I-κB degradation to enhance NF-κB activity in prostate cancer cells, Mol. Cancer Res., 8, 119, 10.1158/1541-7786.MCR-09-0277 · DOI
  51. Muller, 2009, Nuclear–cytosolic transport of COMMD1 regulates NF-κB and HIF-1 activity, Traffic, 10, 514, 10.1111/j.1600-0854.2009.00892.x · DOI
  52. Mao, 2011, COMMD1 (copper metabolism MURR1 domain-containing protein 1) regulates Cullin RING ligases by preventing CAND1 (Cullin-associated Nedd8-dissociated protein 1) binding, J. Biol. Chem., 286, 32355, 10.1074/jbc.M111.278408 · DOI · Paper page
  53. Drevillon, 2011, COMMD1-mediated ubiquitination regulates CFTR trafficking, PLoS ONE, 6, e18334, 10.1371/journal.pone.0018334 · DOI
  54. Lian, 2009, HSCARG regulates NF-κB activation by promoting the ubiquitination of RelA or COMMD1, J. Biol. Chem., 284, 17998, 10.1074/jbc.M809752200 · DOI
  55. van de Sluis, 2007, Increased activity of hypoxia-inducible factor 1 is associated with early embryonic lethality in Commd1 null mice, Mol. Cell. Biol., 27, 4142, 10.1128/MCB.01932-06 · DOI · Paper page
  56. van de Sluis, 2009, COMMD1 promotes pVHL and O2-independent proteolysis of HIF-1 alpha via HSP90/70, PLoS ONE, 4, e7332, 10.1371/journal.pone.0007332 · DOI
  57. Mufti, 2006, XIAP is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders, Mol. Cell, 21, 775, 10.1016/j.molcel.2006.01.033 · DOI · Paper page
  58. Mufti, 2007, XIAP: cell death regulation meets copper homeostasis, Arch. Biochem. Biophys., 463, 168, 10.1016/j.abb.2007.01.033 · DOI
  59. Vonk, 2011, Liver-specific Commd1 knockout mice are susceptible to hepatic copper accumulation, PLoS ONE, 6, e29183, 10.1371/journal.pone.0029183 · DOI
  60. Tao, 2003, The copper toxicosis gene product Murr1 directly interacts with the Wilson disease protein, J. Biol. Chem., 278, 41593, 10.1074/jbc.C300391200 · DOI · Paper page
  61. Huang, 2008, Tumor suppressor ARF promotes non-classic proteasome-independent polyubiquitination of COMMD1, J. Biol. Chem., 283, 11453, 10.1074/jbc.M708544200 · doi:10.1074/jbc.m708544200
  62. Woods, 2012, Charting the landscape of tandem BRCT domain-mediated protein interactions, Sci. Signal., 5, rs6, 10.1126/scisignal.2002255 · DOI
  63. Muller, 2007, Gene expression profiling of liver cells after copper overload in vivo and in vitro reveals new copper-regulated genes, J. Biol. Inorg. Chem., 12, 495, 10.1007/s00775-006-0201-y · DOI
  64. Thoms, 2010, Nucleolar targeting of RelA(p65) is regulated by COMMD1-dependent ubiquitination, Cancer Res., 70, 139, 10.1158/0008-5472.CAN-09-1397 · DOI
  65. van de Sluis, 2010, COMMD1 disrupts HIF-1 <alpha>/<beta> dimerization and inhibits human tumor cell invasion, J. Clin. Invest., 120, 2119, 10.1172/JCI40583 · DOI
  66. Starokadomskyy, 2013, CCDC22 deficiency in humans blunts activation of proinflammatory NF-κB signaling, J. Clin. Invest., 123, 2244, 10.1172/JCI66466 · DOI · Paper page
  67. Forman, 2005, Characterization of the COMMD1 (MURR1) mutation causing copper toxicosis in Bedlington terriers, Anim. Genet., 36, 497, 10.1111/j.1365-2052.2005.01360.x · DOI
  68. Vonk, 2012, The copper-transporting capacity of ATP7A mutants associated with Menkes disease is ameliorated by COMMD1 as a result of improved protein expression, Cell. Mol. Life Sci., 69, 149, 10.1007/s00018-011-0743-1 · DOI
  69. Biasio, 2004, Identification of Murr1 as a regulator of the human delta epithelial sodium channel, J. Biol. Chem., 279, 5429, 10.1074/jbc.M311155200 · DOI
  70. Vonk, 2010, Cu, Zn superoxide dismutase maturation and activity are regulated by COMMD1, J. Biol. Chem., 285, 28991, 10.1074/jbc.M110.101477 · doi:10.1074/jbc.m110.101477
  71. Chang, 2011, COMMD1 regulates the delta epithelial sodium channel (δENaC) through trafficking and ubiquitination, Biochem. Biophys. Res. Commun., 411, 506, 10.1016/j.bbrc.2011.06.149 · DOI

Cited by

See all 121

Metadata

Authors
Bartuzi, P., Hofker, M. H., & van de Sluis, B.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher
Elsevier BV
Published
2013-12
Volume
1832
Issue
12
Pages
2315-2321
ISSN
0925-4439
Cited by
121
References
5
Language
en
Licence
Funders
  • Graduate School for Drug Exploration (GUIDE)
  • University of Groningen
  • NWO ALW (817.02.022)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.